Singapore markets closed

MorphoSys AG (0NDV.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
22.31-0.01 (-0.06%)
As of 06:19PM BST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 326.19%
S&P500 52-week change 323.57%
52-week high 332.37
52-week low 311.84
50-day moving average 328.58
200-day moving average 321.86

Share statistics

Avg vol (3-month) 331.22k
Avg vol (10-day) 324.61k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 828.81M
% held by insiders 116.26%
% held by institutions 174.86%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23.00003:1
Last split date 323 Dec 2008

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -190.61%
Operating margin (ttm)-960.14%

Management effectiveness

Return on assets (ttm)-13.84%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)241.47M
Revenue per share (ttm)6.86
Quarterly revenue growth (yoy)-55.80%
Gross profit (ttm)N/A
EBITDA -444.87M
Net income avi to common (ttm)-468.57M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)131.26M
Total cash per share (mrq)3.49
Total debt (mrq)1.73B
Total debt/equity (mrq)N/A
Current ratio (mrq)1.38
Book value per share (mrq)-6.96

Cash flow statement

Operating cash flow (ttm)-298.22M
Levered free cash flow (ttm)-533.54M